| Dr Ana Amparo Cardenas, MD | |
|
3400 Calloway Dr, Ste 200, Bakersfield, CA 93312-2513 | |
| (661) 410-7546 | |
| (661) 410-7547 |
| Full Name | Dr Ana Amparo Cardenas |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 33 Years |
| Location | 3400 Calloway Dr, Bakersfield, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841292026 | NPI | - | NPPES |
| G86302 | Other | CA | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | G86302 (California) | Primary |
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | G86302 (California) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ana Cardenas Dermatology A Professional Corporation | 6507892247 | 5 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced results from the placebo group analyses of the ADAGIO study that were presented at the 62nd Annual Meeting of the American Academy of Neurology. The ADAGIO study stands out from other Parkinson's disease trials as it is the largest clinical study conducted in patients who were still in the very early stages of their disease course (average time from PD diagnosis of 4.5 months).
A dendritic cell vaccine personalized for each individual based on the patient's own tumor may increase median survival time in those with a deadly form of brain cancer called glioblastoma, an early phase study at UCLA's Jonsson Comprehensive Cancer Center has found.
Environmentalists now have a new cause to take up – the metered dose inhalers (MDIs) used by asthmatic patients to control their airway spasm.
Wound Management Technologies, Inc. a rapidly growing provider of specialty medical products, announced today that its Resorbable Orthopedics operating subsidiary is moving toward productization of its patented orthopedic bone void fillers. The company currently anticipates products to be introduced in Q3 2010, to the bio-products market, estimated to be a multi-billion dollar international market.
› Verified 2 days ago
| Entity Name | Ana Cardenas Dermatology A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114033842 PECOS PAC ID: 6507892247 Enrollment ID: O20050713000826 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced results from the placebo group analyses of the ADAGIO study that were presented at the 62nd Annual Meeting of the American Academy of Neurology. The ADAGIO study stands out from other Parkinson's disease trials as it is the largest clinical study conducted in patients who were still in the very early stages of their disease course (average time from PD diagnosis of 4.5 months).
A dendritic cell vaccine personalized for each individual based on the patient's own tumor may increase median survival time in those with a deadly form of brain cancer called glioblastoma, an early phase study at UCLA's Jonsson Comprehensive Cancer Center has found.
Environmentalists now have a new cause to take up – the metered dose inhalers (MDIs) used by asthmatic patients to control their airway spasm.
Wound Management Technologies, Inc. a rapidly growing provider of specialty medical products, announced today that its Resorbable Orthopedics operating subsidiary is moving toward productization of its patented orthopedic bone void fillers. The company currently anticipates products to be introduced in Q3 2010, to the bio-products market, estimated to be a multi-billion dollar international market.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ana Amparo Cardenas, MD 3400 Calloway Dr, Ste 200, Bakersfield, CA 93312-2513 Ph: (661) 410-7546 | Dr Ana Amparo Cardenas, MD 3400 Calloway Dr, Ste 200, Bakersfield, CA 93312-2513 Ph: (661) 410-7546 |
News Archive
Teva Pharmaceutical Industries Ltd. today announced results from the placebo group analyses of the ADAGIO study that were presented at the 62nd Annual Meeting of the American Academy of Neurology. The ADAGIO study stands out from other Parkinson's disease trials as it is the largest clinical study conducted in patients who were still in the very early stages of their disease course (average time from PD diagnosis of 4.5 months).
A dendritic cell vaccine personalized for each individual based on the patient's own tumor may increase median survival time in those with a deadly form of brain cancer called glioblastoma, an early phase study at UCLA's Jonsson Comprehensive Cancer Center has found.
Environmentalists now have a new cause to take up – the metered dose inhalers (MDIs) used by asthmatic patients to control their airway spasm.
Wound Management Technologies, Inc. a rapidly growing provider of specialty medical products, announced today that its Resorbable Orthopedics operating subsidiary is moving toward productization of its patented orthopedic bone void fillers. The company currently anticipates products to be introduced in Q3 2010, to the bio-products market, estimated to be a multi-billion dollar international market.
› Verified 2 days ago
Lynn Cranmer, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3733 San Dimas St, Bakersfield, CA 93301 Phone: 800-353-5400 | |
Dr. Jeffrey J Crowley, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5101 Commerce Dr, Suite 101, Bakersfield, CA 93309 Phone: 661-327-3756 Fax: 661-327-2332 | |
Mr. Michael A Macduff, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2215 G Street, Bakersfield, CA 93301 Phone: 661-324-1312 Fax: 661-324-0901 | |
Kristin Elaine Totoraitis, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5101 Commerce Dr Ste 101, Bakersfield, CA 93309 Phone: 661-327-3756 | |
Alexander F Wong, PA Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9710 Brimhall Rd, Bakersfield, CA 93312 Phone: 618-296-7476 Fax: 661-829-6937 | |
Dr. Shanna Treanor, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5101 Commerce Dr, Suite 101, Bakersfield, CA 93309 Phone: 661-327-3756 Fax: 661-327-2332 |